Ozempic Semaglutide 0.25mg Pre-Filled Pen for Diabetes & Weight Loss 1s

• Prescription injectable medicine for type 2 diabetes (and off-label for weight management) • Contains semaglutide (GLP-1 receptor agonist) • Strength: 0.25 mg per dose (starting dose) • Pre-filled, multi-dose pen delivering 4 × 0.25 mg doses (1 month supply at initiation) • Includes 4 NovoFine Plus 32G disposable needles (ultra-thin, 4 mm) • Once-weekly subcutaneous injection • Requires a doctor’s prescription

Ozempic 0.25 mg is the starting dose pen of once-weekly semaglutide, a glucagon-like peptide-1 (GLP-1) analogue that lowers blood glucose by increasing insulin secretion, reducing glucagon, slowing gastric emptying, and reducing appetite. It is indicated as an adjunct to diet and exercise for adults with type 2 diabetes mellitus and has proven cardiovascular and kidney-protective benefits. Many patients also experience significant weight loss (average 5–15% of body weight). The pen is dialled to deliver exactly 0.25 mg per injection for the first 4 weeks, after which patients usually move to the 0.5 mg or 1 mg pen. Benefits • Once-weekly injection – high adherence • Superior A1C reduction (1.5–2% average) • Significant weight loss in most patients • Reduces risk of major cardiovascular events (heart attack, stroke) • Slows progression of diabetic kidney disease • Improves quality of life and reduces need for other medications How to Use • Inject 0.25 mg subcutaneously once weekly, any time of day, with or without meals • Common sites: abdomen, thigh, or upper arm • Use a new needle for each injection; prime pen before first use • After 4 weeks (4 doses), consult doctor – usually increase to 0.5 mg weekly • Store unopened pens in fridge (2–8°C); in-use pen can be kept at room temperature (